| 1 |
35455642 | Impact of the Genotype and Phenotype of CYP3A and P-gp on the Apixaban and Rivaroxaban Exposure in a Real-World Setting. | 2022 Mar 24 |
1 |
| 2 |
21646440 | Influence of Panax ginseng on cytochrome P450 (CYP)3A and P-glycoprotein (P-gp) activity in healthy participants. | 2012 Jun |
1 |
| 3 |
19232844 | Methadone metabolism and clearance are induced by nelfinavir despite inhibition of cytochrome P4503A (CYP3A) activity. | 2009 May 1 |
1 |
| 4 |
17230498 | Pharmacokinetics of fexofenadine enantiomers in healthy subjects. | 2007 Mar |
2 |
| 5 |
15601808 | Evaluation of first-pass cytochrome P4503A (CYP3A) and P-glycoprotein activities using alfentanil and fexofenadine in combination. | 2005 Jan |
2 |
| 6 |
11240975 | The effect of rifampin administration on the disposition of fexofenadine. | 2001 Mar |
1 |
| 7 |
10496299 | Clinical pharmacokinetics of troglitazone. | 1999 Aug |
1 |